Hardly hungry while taking GLP-1 medication: how can you keep eating well?
Reduced appetite whilst on GLP-1: small portions, staying hydrated and planning meals to ensure nutritional needs are met without feeling forced.
Reduced appetite whilst on GLP-1: small portions, staying hydrated and planning meals to ensure nutritional needs are met without feeling forced.
Injectable slimming products on social media: spot dubious claims, unclear supply chains and false guarantees.
Retatrutide in 2026: study populations, phase 3 results, adverse effects and limitations of a treatment that is still experimental.
Mounjaro and cardiovascular risk: understanding the new US indication, the results of the SURPASS-CVOT trial and their limitations.
GLP-1 tablets: US approvals, differences compared to injections, and questions to ask before considering treatment in Morocco.
Weight regain after treatment with semaglutide or tirzepatide is common. Understanding the mechanism helps you plan ahead with your doctor.
Semaglutide, tirzepatide, oral GLP-1e and retatrutide: mechanisms of action, indications, results, risks and regulatory status as of August 2026.
Protein, weight training, weight loss rate and monitoring: the priorities for maintaining lean body mass whilst on GLP-1 treatment.